Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic

被引:10
作者
Geller, Andrew I. [1 ]
Lovegrove, Maribeth C. [1 ]
Lind, Jennifer N. [1 ]
Datta, S. Deblina [1 ]
Budnitz, Daniel S. [1 ]
机构
[1] CDC COVID 19 Response Team, Atlanta, GA USA
关键词
D O I
10.1001/jamainternmed.2021.0299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:869 / 872
页数:4
相关论文
共 6 条
[1]  
American Society of Health-System Pharmacists, ASS EV COVID 19 REL
[2]  
COVID-19 Treatment Guidelines Panel, COR DIS 2019 COVID 1
[3]   US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020 [J].
Shehab, Nadine ;
Lovegrove, Maribeth ;
Budnitz, Daniel S. .
JAMA INTERNAL MEDICINE, 2020, 180 (10) :1384-1386
[4]  
US Department of Health and Human Services Centers for Disease Control and Prevention, CDC COVID DAT TRACK
[5]  
US Department of Health and Human Services Food and Drug Administration, COVID 19 EM US AUTH
[6]  
US Department of Health and Human Services National Institutes of Health National Cancer Institute, JOINP TREND AN SOFTW